OKYO Pharma Receives $1.4 Million in Non-Dilutive Funding
22 janv. 2025 07h00 HE
|
OKYO Pharma LTD
LONDON and NEW YORK, Jan. 22, 2025 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing innovative therapies for the treatment of neuropathic...
DT Midstream Announces Closing of Midwest Pipeline Acquisition
31 déc. 2024 09h00 HE
|
DT Midstream, Inc.
DETROIT, Dec. 31, 2024 (GLOBE NEWSWIRE) -- DT Midstream, Inc. (NYSE: DTM) today announced that it has successfully closed on the acquisition of a portfolio of three FERC-regulated natural gas...
Azuria Water Solutions Announces Acquisition of Pipe Pros LLC
20 déc. 2024 10h40 HE
|
Azuria Water Solutions
Azuria Water Solutions announces the acquisition of Pipe Pros LLC
Azuria Water Solutions Announces the Acquisition of a portion of Miller Pipeline’s Municipal Services Division
06 nov. 2024 09h00 HE
|
Azuria Water Solutions
Azuria Water Solutions™ today announced the acquisition of a portion of Miller Pipeline LLC’s municipal services division operations.
Tevogen Bio Plans to Share $1B+ Revenue Potential of its Pipeline Portfolio Beginning Week of October 14, 2024
11 oct. 2024 15h59 HE
|
Tevogen Bio Inc
Tevogen Bio Plans to Share $1B+ Revenue Potential of its Pipeline Portfolio Beginning Week of October 14, 2024
Tevogen Bio Extends Pipeline Prioritizing Oncology and Long COVID
11 oct. 2024 12h12 HE
|
Tevogen Bio Inc
Developing therapeutic products that not only treat cancer but also enable oncology patients to maintain uninterrupted therapy.Expanding its pipeline to include non-oncology products, an opportunistic...
Mural Oncology’s First Virtual Investor Day to Highlight Late-Stage Clinical Progress
26 sept. 2024 07h00 HE
|
Mural Oncology, Inc.
Key data readouts for the company’s late-stage, potentially registrational trials of nemvaleukin are expected in late Q1/early Q2 2025 for platinum-resistant ovarian cancer and Q2 2025 for mucosal...
Barinthus Bio Announces Strategic Pipeline Prioritization Following Positive Interim Data from VTP-300 in Chronic Hepatitis B Virus Infections
12 juin 2024 16h01 HE
|
Barinthus Biotherapeutics
Barinthus Bio Announces Strategic Pipeline Prioritization Following Positive Interim Data from VTP-300 in Chronic Hepatitis B Virus Infections
Azuria Announces Acquisition of Infrastructure Services Group LLC and Subsidiaries
11 juin 2024 10h36 HE
|
Azuria Water Solutions
Azuria Announces Acquisition of Infrastructure Services Group LLC and Subsidiaries
AUROBAC THERAPEUTICS Presents its R&D Strategy & Pipeline and Announces New Development Program in Partnership with Boehringer Ingelheim
03 juin 2024 08h14 HE
|
AUROBAC THERAPEUTICS
AUROBAC THERAPEUTICS to advance ATX101 in septic shock, and multiple preclinical and discovery programs targeting Gram-negative pathogens. Lyon (France), June 3, 2024 AUROBAC THERAPEUTICS, a...